Five shares sold at $0.645 at the close, knocking the price down from $0.65. This market is incredible. Spec garbage running on fumes is flying, and this de-risked cashed up gem is sailing under the radar.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status